Sanga Emmanuel

Sanga Emmanuel has a diverse work experience spanning several companies and roles. From 2015 onwards, they worked at Insys Therapeutics, Inc. as the VP - Chief Compliance Officer, where they were responsible for the company's compliance program. Prior to that, from 2014 to 2015, they were the Director of Corporate Compliance at Biogen, where their primary responsibilities included designing and implementing training on Corporate Compliance standards and processes. From 2012 to 2014, they worked at Organogenesis Inc., first as a Compliance Specialist, where they developed and revised policies and procedures for the company's Comprehensive Healthcare Compliance Program, and later as the Senior Compliance Counsel, overseeing a system for handling compliance violations. From 2008 to 2011, they were an Associate at Nixon Peabody, where they represented and advised medical device and pharmaceutical companies in Department of Justice investigations into False Claims Act violations.

Sanga Emmanuel has a Bachelor of Arts (B.A.) degree in Communications Arts from the University of New Hampshire-Manchester. Sanga attended this university from 2001 to 2004. Following their undergraduate studies, they pursued a Juris Doctor (JD) degree at Boston University School of Law from 2005 to 2008. Apart from their formal education, there is no information provided regarding any additional certifications or the specific institution from which they obtained the "Certified Healthcare Compliance (CHC)" certification.